93 related articles for article (PubMed ID: 19966658)
1. Expanding the phenotype of a neurofibromatosis type 1-like syndrome: a patient with a SPRED1 mutation and orbital manifestations.
Lane KA; Anninger WV; Katowitz JA
Ophthalmic Plast Reconstr Surg; 2009; 25(5):399-401. PubMed ID: 19966658
[TBL] [Abstract][Full Text] [Related]
2. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
[TBL] [Abstract][Full Text] [Related]
3. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype.
Pasmant E; Sabbagh A; Hanna N; Masliah-Planchon J; Jolly E; Goussard P; Ballerini P; Cartault F; Barbarot S; Landman-Parker J; Soufir N; Parfait B; Vidaud M; Wolkenstein P; Vidaud D; France RN
J Med Genet; 2009 Jul; 46(7):425-30. PubMed ID: 19366998
[TBL] [Abstract][Full Text] [Related]
4. SPRED1 mutations (Legius syndrome): another clinically useful genotype for dissecting the neurofibromatosis type 1 phenotype.
Spurlock G; Bennett E; Chuzhanova N; Thomas N; Jim HP; Side L; Davies S; Haan E; Kerr B; Huson SM; Upadhyaya M
J Med Genet; 2009 Jul; 46(7):431-7. PubMed ID: 19443465
[TBL] [Abstract][Full Text] [Related]
5. SPRED 1 mutations in a neurofibromatosis clinic.
Muram-Zborovski TM; Stevenson DA; Viskochil DH; Dries DC; Wilson AR; Rong Mao
J Child Neurol; 2010 Oct; 25(10):1203-9. PubMed ID: 20179001
[TBL] [Abstract][Full Text] [Related]
6. Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype.
Brems H; Chmara M; Sahbatou M; Denayer E; Taniguchi K; Kato R; Somers R; Messiaen L; De Schepper S; Fryns JP; Cools J; Marynen P; Thomas G; Yoshimura A; Legius E
Nat Genet; 2007 Sep; 39(9):1120-6. PubMed ID: 17704776
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive RNA Analysis of the NF1 Gene in Classically Affected NF1 Affected Individuals Meeting NIH Criteria has High Sensitivity and Mutation Negative Testing is Reassuring in Isolated Cases With Pigmentary Features Only.
Evans DG; Bowers N; Burkitt-Wright E; Miles E; Garg S; Scott-Kitching V; Penman-Splitt M; Dobbie A; Howard E; Ealing J; Vassalo G; Wallace AJ; Newman W; ; Huson SM
EBioMedicine; 2016 May; 7():212-20. PubMed ID: 27322474
[TBL] [Abstract][Full Text] [Related]
8. A cost savings approach to SPRED1 mutational analysis in individuals at risk for neurofibromatosis type 1.
Muram TM; Stevenson DA; Watts-Justice S; Viskochil DH; Carey JC; Mao R; Jackson B
Am J Med Genet A; 2013 Mar; 161A(3):467-72. PubMed ID: 23401230
[TBL] [Abstract][Full Text] [Related]
9. Dysplasia of the orbit and adjacent bone associated with plexiform neurofibroma and ocular disease in 42 NF-1 patients.
Friedrich RE; Stelljes C; Hagel C; Giese M; Scheuer HA
Anticancer Res; 2010 May; 30(5):1751-64. PubMed ID: 20592374
[TBL] [Abstract][Full Text] [Related]
10. [Germinal loss-of-function mutations in the spred1 gene cause conditions similar to neurofibromatosis type 1].
Dereure O
Ann Dermatol Venereol; 2008; 135(6-7):529-30. PubMed ID: 18598812
[No Abstract] [Full Text] [Related]
11. Plexiform neurofibroma of the eye region occurring in patients without neurofibromatosis type 1.
Bechtold D; Hove HD; Prause JU; Heegaard S; Toft PB
Ophthalmic Plast Reconstr Surg; 2012; 28(6):413-5. PubMed ID: 22836801
[TBL] [Abstract][Full Text] [Related]
12. Family with Legius syndrome (neurofibromatosis type 1-like syndrome).
Sakai N; Maeda T; Kawakami H; Uchiyama M; Harada K; Tsuboi R; Mitsuhashi Y
J Dermatol; 2015 Jul; 42(7):703-5. PubMed ID: 25981987
[TBL] [Abstract][Full Text] [Related]
13. Neurofibromatosis type 1 molecular diagnosis: what can NGS do for you when you have a large gene with loss of function mutations?
Pasmant E; Parfait B; Luscan A; Goussard P; Briand-Suleau A; Laurendeau I; Fouveaut C; Leroy C; Montadert A; Wolkenstein P; Vidaud M; Vidaud D
Eur J Hum Genet; 2015 May; 23(5):596-601. PubMed ID: 25074460
[TBL] [Abstract][Full Text] [Related]
14. [Neurofibromatosis type 1 (von Recklinghausen's disease or peripheral neurofibromatosis): from phenotype to gene].
Sabol Z; Kipke-Sabol L
Lijec Vjesn; 2005; 127(11-12):303-11. PubMed ID: 16583938
[TBL] [Abstract][Full Text] [Related]
15. Review and update of SPRED1 mutations causing Legius syndrome.
Brems H; Pasmant E; Van Minkelen R; Wimmer K; Upadhyaya M; Legius E; Messiaen L
Hum Mutat; 2012 Nov; 33(11):1538-46. PubMed ID: 22753041
[TBL] [Abstract][Full Text] [Related]
16. Pigmentary findings in neurofibromatosis type 1-like syndrome (Legius syndrome): potential diagnostic dilemmas.
Stevenson D; Viskochil D
JAMA; 2009 Nov; 302(19):2150-1. PubMed ID: 19920242
[No Abstract] [Full Text] [Related]
17. The first Slovak Legius syndrome patient carrying the SPRED1 gene mutation.
Sekelska M; Briatkova L; Olcak T; Bolcekova A; Ilencikova D; Kadasi L; Zatkova A
Gen Physiol Biophys; 2017 Apr; 36(2):205-210. PubMed ID: 28150585
[TBL] [Abstract][Full Text] [Related]
18. Ipsilateral Sphenoid Wing Dysplasia, Orbital Plexiform Neurofibroma and Fronto-Parietal Dermal Cylindroma in a Patient with Segmental Neurofibromatosis.
Friedrich RE; Hagel C; Mautner VF
Anticancer Res; 2015 Dec; 35(12):6813-8. PubMed ID: 26637901
[TBL] [Abstract][Full Text] [Related]
19. [Magnetic resonance imaging findings of orbital disease in neurofibromatosis type 1 patients].
Fu L; Wang ZC; Xian JF; Li J; Zhang ZY
Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(29):2042-5. PubMed ID: 23253805
[TBL] [Abstract][Full Text] [Related]
20. Analysis of orbital plain radiographs for orbital deformities in neurofibromatosis type 1 patients, with special reference to alterations of the orbital rim as indicators of adjacent plexiform neurofibroma.
Friedrich RE; Rother J; Christ G; Lehmann M; Eulenburg CG; Giese M; Scheuer HA
Anticancer Res; 2013 Mar; 33(3):1081-90. PubMed ID: 23482785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
